Jill Schwartz

Title: The Innovative Contributions of Jill Schwartz

Introduction

Jill Schwartz is a prominent inventor based in Garrett Park, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. With a total of 2 patents, her work focuses on improving the efficacy and delivery of antiviral medications and long-acting contraceptives.

Latest Patents

One of her latest patents is titled "Pharmaceutical compositions and methods of making on demand solid dosage formulations." This patent discloses a pharmaceutical composition that includes a therapeutically effective amount of one or more antiviral active pharmaceutical ingredients combined with a pharmaceutically acceptable excipient. The composition is designed as a solid dosage form that provides sustained release of the antiviral active ingredient when administered as a vaginal or rectal insert.

Another notable patent is for the "Formulation of long-acting levonorgestrel butanoate injectable depot suspension." This invention presents an improved long-acting injectable depot suspension formulation of levonorgestrel butanoate (LB) that displays progestational effects. It addresses the issues of aggregation and physical instability commonly associated with LB injectable depot products, offering a longer duration of action of at least four months. This formulation has potential applications in contraception and the treatment or prevention of progestin/progesterone-sensitive reproductive tract dysfunctions and disorders.

Career Highlights

Jill Schwartz is affiliated with Eastern Virginia Medical School, where she continues to advance her research and development efforts in pharmaceutical sciences. Her work is characterized by a commitment to enhancing patient care through innovative drug delivery systems.

Collaborations

Jill collaborates with esteemed colleagues such as Timothy J. McCormick and Gustavo F. Doncel, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jill Schwartz's contributions to pharmaceutical innovation exemplify the impact of dedicated inventors in the medical field. Her patents reflect a commitment to improving healthcare outcomes through advanced drug formulations.